The world of finance, connected.EN / Global
AL
CompanyCompany profileReviewed 2026-10-23

ALCON INC

Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.

Sources and references ↗
COMPANY PROFILE / 16 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Ticker / security symbols
ALC [1]
Listing exchanges
NYSE [1]
SEC industry
Ophthalmic Goods [1]
Business sectors
pharmaceutical industry [2]
Company / filing name
ALCON INC [1]
Headquarters location
Geneva [2]
Business address
6201 SOUTH FREEWAY, FORT WORTH, TX, 76134 [1]
Founded
1945 [2]
Legal form
Aktiengesellschaft [2]
Incorporation jurisdiction
Switzerland [1]
Official website
www.alcon.com ↗ [2]
Fiscal year end
December 31 (SEC record) [1]
ISIN (reported securities)
CH0432492467 [2]
CIK
0001167379 [1]
SIC code
3851 [1]
Country in background record
Switzerland [2]

Company positioning and business

Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. [3]

Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. [3]

Background text: Wikipedia contributors, Alcon. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Financial year, securities and disclosures

The SEC submissions record gives ALCON INC a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]

Listed securities: ALC (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]

History and key events

  1. Founding / inception date recorded in Wikidata. [2]

  2. Form 20-F filed; reporting period ends 2025-12-31. [5]

Financial results and regulatory disclosures

Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.

Source-verified relationships

ALCON INC → Listed on → NYSE [1]
ALCON INC → SEC industry classification → Ophthalmic Goods [1]

Related entities and concepts

Frequently asked questions

When was ALCON INC founded?

Founded: 1945. The linked source provides the background record. [2]

Where is the headquarters of ALCON INC?

Headquarters location: Geneva. The linked source provides the background record. [2]

Which business sectors are recorded for ALCON INC?

Business sectors: pharmaceutical industry. The linked source provides the background record. [2]

RELATION MAP

ALCON INC relationship map

Drag to rotate · Scroll to zoom
ALCON INC

Select a node to inspect its relationship and source.

2 verified direct relationships. Industry peers are not relationship edges.

Sources and review dates

  1. SEC — ALCON INC filing identity and securities ↗
  2. Wikidata — company background record (CC0) ↗
  3. Wikipedia contributors — Alcon (CC BY-SA 4.0) ↗
  4. SEC securities directory ↗
  5. Company chronology / filing ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.